英文摘要 |
Peritonitis and catheter-related infections are the most common complications of peritoneal dialysis (PD) treatment. The aim of this review article was to analyze the infection routes in PD patients and the treatment specificity of pathogens. Present treatment recommendations of peritonitis and catheter-related infection have become more accurate and standardized. Staphylococcus epidermidis has been the most frequent pathogen. Relapsing peritonitis is an important issue and it probably has some links with biofilm-related infections. The regular use of intranasal or exit-site mupirocin decreases the risk of S. aureus infection. If the clinical response is less effective than expected, rifampin 600mg/day P.O. can be added to the I.P. antibiotics for S. aureus infection. Vancomycin should be used in infections of ORSA (oxacillin-resistant S.aureus) or ampicillin-resistant enterococcus (ARE). Besides, intra-abdominal pathology must be considered in enterococcus infection. For infection of a single gram-negative organism, such as Escherichia coli, klebsiella, or proteus, utilization of ceftazidime or aminoglycoside must be guided by in vitro sensitivity testing and by patient’s residual renal function. For a infection of multiple gram-negative organisms or anaerobic organisms, it is crucial to consider the possibility of intra-abdominal pathology, necessitating surgical exploration. Peritonitis due to Pseudomonas species is a serious complication in CAPD patients. In treating Pseudomonas, it is necessary to combine aminoglycoside or ciprofloxacin with ceftazidime to have a chance to control this infection. Fungal organisms and tuberculous peritonitis are relatively rare complications of PD. Clinically, these should be considered in patients with peritonitis who are not responding to appropriate antibiotic treatment. |